Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ziopharm Oncology IN (ZIOP)

Ziopharm Oncology IN (ZIOP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is the Options Market Predicting a Spike ZIOPHARM (ZIOP) Stock?

Investors need to pay close attention to ZIOPHARM (ZIOP) stock based on the movements in the options market lately.

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology to Participate in September Investor Conferences

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), today announced that Kevin S. Boyle, Sr., Chief Executive Officer of Ziopharm, is scheduled to participate in five upcoming virtual...

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions

Mr. Boyle brings over 20 years of executive business leadership in CEO, CFO and operational leadership roles

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates

Accomplished key milestones in groundbreaking TCR-T Library program, including commissioning of Company's manufacturing facility and presentation of favorable preclinical data

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that management will host a conference call and webcast on Monday, August 9, at 4:30 p.m. EDT to provide a corporate update and discuss financial...

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology to Participate in Upcoming Conferences

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), a clinical-stage cellular therapy company focused on hematologic and solid tumor cancers, today announced that Company management will...

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

- Highlighted distinctive cellular therapy program, market opportunity and value proposition

ZIOP : 1.9000 (+4.40%)
Ziopharm: Q1 Earnings Snapshot

BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Thursday reported a loss of $21.6 million in its first quarter.

ZIOP : 1.9000 (+4.40%)
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates

- Annual shareholder meeting planned for May 19, 2021

ZIOP : 1.9000 (+4.40%)
ZIOPHARM Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM...

ZIOP : 1.9000 (+4.40%)

Barchart Exclusives

Meats Experience Seasonal Weakness After A Bullish WASDE report
It is the offseason for animal protein demand, and prices have been moving lower over the past weeks. Meanwhile, the latest WASDE report was not bearish for beef and pork prices. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar